Infections, Nosocomial Clinical Trial
Official title:
Linezolid (PNU-10766/PNU10766SS) in the Treatment of MRSA Infections in Patients Whose Conventional Therapy Has Failed, or Who Are Intolerant to Conventional Therapy; an Open-label, Multi-center Trial
Use of linezolid in patients with methicillin-resistant Staphylococcus aureus infections in Japan
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01089712 -
Management Practices and the Risk of Infection Following Cardiac Surgery
|
N/A | |
Completed |
NCT00502801 -
An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-acquired) Pneumonia
|
Phase 2 |